Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TEVA Financial Statements and Analysis

NYSE : TEVA

Teva Pharmaceutical Industries Limited

$16.74
-0.26-1.53%
At Close 4:00 PM
$16.75
0.01+0.06%
After-Market 07:55 PM
56.19
B-ESG ScoreESG Rating

TEVA FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

TEVA Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-12-312024-09-302024-06-302024-03-312023-12-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420242023
periodQ4Q3Q2Q1Q4
revenue4.229B4.332B4.162B3.832B4.457B
cost of revenue2.109B2.184B2.14B2.048B2.041B
gross profit2.12B2.148B2.022B1.784B2.416B
gross profit ratio0.5010.4960.4860.4660.542
research and development expenses248.00M240.00M269.00M242.00M227.00M
general and administrative expenses302.00M298.00M283.00M278.00M292.00M
selling and marketing expenses650.00M626.00M656.00M608.00M610.00M
selling general and administrative expenses952.00M924.00M939.00M886.00M902.00M
other expenses001.00M18.00M-36.00M
operating expenses1.20B1.164B1.208B1.128B1.129B
cost and expenses3.309B3.348B3.348B3.176B3.17B
interest income00000
interest expense0272.00M241.00M250.00M221.00M
depreciation and amortization0259.00M259.00M272.00M266.00M
ebitda-29.00M210.00M254.00M45.00M1.451B
ebitda ratio-0.0070.0480.2580.2420.326
operating income-29.00M-51.00M814.00M656.00M722.00M
operating income ratio-0.007-0.0120.1960.1710.162
total other income expenses net-218.00M-273.00M-241.00M-249.00M-527.00M
income before tax-247.00M-324.00M-246.00M-467.00M473.00M
income before tax ratio-0.058-0.075-0.059-0.1220.106
income tax expense-30.00M69.00M630.00M-52.00M41.00M
net income-217.00M-437.00M-845.00M-139.00M429.00M
net income ratio-0.051-0.101-0.203-0.0360.096
eps-0.19-0.39-0.75-0.120.41
eps diluted-0.19-0.39-0.75-0.120.41
weighted average shs out1.133B1.133B1.133B1.123B1.121B
weighted average shs out dil1.157B1.133B1.133B1.123B1.137B
Graph

TEVA Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents3.319B2.258B2.991B3.226B2.249B
short term investments00000
cash and short term investments3.319B2.258B2.991B3.226B2.249B
net receivables3.462B3.766B3.456B3.408B3.385B
inventory3.959B3.927B3.949B4.021B4.051B
other current assets1.574B1.681B1.901B505.00M521.00M
total current assets12.314B11.632B12.297B12.485B11.425B
property plant equipment net6.036B5.931B5.982B6.147B6.028B
goodwill16.124B16.488B17.007B17.177B16.885B
intangible assets4.756B4.853B5.056B5.387B5.525B
goodwill and intangible assets20.88B21.341B22.063B22.564B22.41B
long term investments0008.00M0
tax assets2.07B2.00B1.96B1.812B1.748B
other non current assets458.00M434.00M471.00M462.00M477.00M
total non current assets29.444B29.706B30.476B30.993B30.663B
other assets0001.00M0
total assets41.758B41.338B42.773B43.479B42.088B
account payables2.371B2.366B2.439B2.602B2.28B
short term debt2.58B2.094B3.06B1.672B1.479B
tax payables00000
deferred revenue0006.917B6.622B
other current liabilities8.846B8.577B8.293B1.056B1.013B
total current liabilities13.797B13.037B13.792B12.247B11.394B
long term debt16.695B16.828B16.878B18.481B18.819B
deferred revenue non current0281.00M294.00M03.818B
deferred tax liabilities non current0553.00M569.00M606.00M544.00M
other non current liabilities4.882B4.356B3.991B4.019B2.00M
total non current liabilities21.577B21.737B21.438B23.106B23.183B
other liabilities00000
capital lease obligations295.00M281.00M294.00M320.00M324.00M
total liabilities35.374B34.774B35.23B35.353B34.577B
preferred stock021.266B20.518B15.554B0
common stock58.00M58.00M58.00M57.00M57.00M
retained earnings-14.956B-14.519B-13.673B-13.534B-13.87B
accumulated other comprehensive income loss-2.769B-2.88B-2.775B-2.697B-2.91B
other total stockholders equity23.732B23.701B23.668B8.126B23.652B
total stockholders equity6.065B6.359B7.278B7.506B6.929B
total equity6.384B6.563B7.543B8.126B7.511B
total liabilities and stockholders equity41.758B41.337B42.773B43.479B42.088B
minority interest319.00M204.00M265.00M620.00M582.00M
total investments0008.00M0
total debt19.275B18.922B19.938B20.153B20.298B
net debt15.956B16.664B16.947B16.927B18.049B
Graph

TEVA Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax-53.00M-424.00M-189.00M32.00M-199.00M
stock based compensation29.00M32.00M28.00M28.00M31.00M
change in working capital0-10.00M-497.00M326.00M-238.00M
accounts receivables339.00M317.00M295.00M421.00M362.00M
inventory00000
accounts payables00000
other working capital0-10.00M-497.00M-421.00M-600.00M
other non cash items1.263B1.958B1.268B99.00M40.00M
net cash provided by operating activities693.00M420.00M171.00M1.184B5.00M
investments in property plant and equipment-148.00M-97.00M-124.00M-119.00M-149.00M
acquisitions net01.00M-79.00M010.00M
purchases of investments-1.00M-43.00M-12.00M-2.00M-38.00M
sales maturities of investments40.00M000-10.00M
other investing activites377.00M-42.00M-12.00M422.00M371.00M
net cash used for investing activites268.00M-139.00M-215.00M301.00M184.00M
debt repayment0-956.00M0-500.00M-1.20B
common stock issued00000
common stock repurchased00000
dividends paid00000
other financing activites0-10.00M-87.00M-76.00M624.00M
net cash used provided by financing activities0-966.00M-87.00M-576.00M-576.00M
effect of forex changes on cash0-49.00M-104.00M68.00M-33.00M
net change in cash1.061B-733.00M-235.00M977.00M-420.00M
cash at end of period3.319B2.258B2.991B3.227B2.25B
cash at beginning of period2.258B2.991B3.226B2.25B2.67B
operating cashflow693.00M420.00M171.00M1.184B5.00M
capital expenditure-148.00M-97.00M-124.00M-119.00M-149.00M
free cash flow545.00M323.00M47.00M1.065B-144.00M
Graph

Frequently Asked Questions

How did Teva Pharmaceutical Industries Limited do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, TEVA generated $4.23B in revenue last quarter, while its costs came in at $2.11B.

Last quarter, how much Gross Profit did Teva Pharmaceutical Industries Limited report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Teva Pharmaceutical Industries Limited reported a $2.12B Gross Profit for the quarter ended Sep 30, 2024.

Have TEVA's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. TEVA incurred $1.20B worth of Operating Expenses, while it generated -$29.00M worth of Operating Income.

How much Net Income has TEVA posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Teva Pharmaceutical Industries Limited, the company generated -$217.00M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Teva Pharmaceutical Industries Limited have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Teva Pharmaceutical Industries Limited as of the end of the last quarter was $3.32B.

What are TEVA's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, TEVA had Total Net Receivables of $3.46B.

In terms of Total Assets and Current Assets, where did Teva Pharmaceutical Industries Limited stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of TEVA were $12.31B, while the Total Assets stand at $41.76B.

As of the last quarter, how much Total Debt did Teva Pharmaceutical Industries Limited have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of TEVA's debt was $19.28B at the end of the last quarter.

What were TEVA's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, TEVA reported total liabilities of $35.37B.

How much did TEVA's Working Capital change over the last quarter?

Working Capital Change for TEVA was $0.00 over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

TEVA generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. TEVA generated $693.00M of Cash from Operating Activities during its recently reported quarter.

What was TEVA's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. TEVA reported a $1.06B Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph